Metagenomi Therapeutics MGX
NASDAQ MGX
$0.80 -0.02 (-1.97%)
As of: Oct 23, 2026 · 3:33 PM EDT

Metagenomi Therapeutics (MGX) Net Equity Issued and Repurchased (2023 - 2025)

Updated

Metagenomi Therapeutics' Net Equity Issued and Repurchased came in at $93,000 for Q4 2025, down 14.7% from the prior quarter.

Analysis

Metagenomi Therapeutics (MGX) Net Equity Issued and Repurchased (2023 - 2025) Analysis & Trends

For FY2025, Metagenomi Therapeutics' Net Equity Issued and Repurchased was $202,000, down 99.8% from FY2024.

  • Going back by year, Net Equity Issued and Repurchased was $84.01 million in FY2024 and $4.3 million in FY2023.
  • The Q4 2025 figure represents the lowest quarterly Net Equity Issued and Repurchased since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,130.49 Bn 1,099.07 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 635.65 Bn 555.51 Bn 17.30 Bn -966.00 Mn
3 AbbVie 505.44 Bn 478.55 Bn 12.70 Bn -9.00 Mn
4 Merck 358.27 Bn 312.65 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 291.57 Bn 255.56 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 265.15 Bn 238.84 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.41 Bn 192.81 Bn 7.24 Bn -
8 Gilead Sciences 195.01 Bn 169.21 Bn 6.22 Bn -346.00 Mn
9 Pfizer 171.23 Bn 117.87 Bn 10.94 Bn -
10 Metagenomi Therapeutics 30.13 Mn -575.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 109,000.00
Sep 30, 2024 -492,000.00
Jun 30, 2024 -2.03 Mn
Mar 31, 2024 86.54 Mn
Dec 31, 2023 -1.33 Mn
Sep 30, 2023 -1.91 Mn
Mar 31, 2023 4.30 Mn
API Access

Metagenomi Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=MGX&period=max&api_key=YOUR_API_KEY